The MAVERICS graft system is a small, flexible tube encased in a nitinol scaffold that replaces the need for blood vessel harvesting in the heart bypass surgery patient, creating a more efficient, cost-effective, and less invasive procedure.
SAVE A LOVED ONE
The Medical 21 graft is a small, flexible tube encased in a nitinol scaffold that replaces the need for blood vessel harvesting in the heart bypass surgery patient, creating a more efficient, cost-effective, and less invasive procedure.
Yes, you may continue to use the same sewing techniques you already use. However, you will be spared the work of harvesting vessels from the body.
The Medical 21 team is comprised of industry professionals who excel at their work, even when the odds are stacked against them. If you look at the track record of our Founder, Manny Villafaña, he has always created medical devices that people said couldn’t be done. There was a time when pacemakers lasted only 12–18 months; Manny made a pacemaker that would last more than ten years. “That’s impossible!” everyone said, but he did it.
At St. Jude Medical, Manny and his team developed a heart valve using a technology that no one had ever used before and that people said couldn’t be done. Everyone else was making heart valves out of metal, hoping to create strength in the valve. Manny made the St. Jude valve out of glass (pyrolytic carbon), which people thought would be too fragile. The St. Jude heart is now the most used prosthesis in the world. Later, Manny started ATS Medical, and they developed an even better version of that valve using some of the same principles. Medtronic, Inc. presently owns ATS Medical.
By using the Medical 21 graft, your surgeon won’t have to harvest or strip vessels from your legs, arms, or other areas of your body. Our graft will decrease your time in surgery, reduce pain, prevent additional scarring, and decrease your risk of infection.
We are a developmental stage medical technology company that is revolutionizing heart bypass surgery with an artificial graft called MAVERICS.
Founded by Manny Villafaña, Ph.D.Sc., a “Living Legend of Medicine,” our company has developed a graft that allows the heart bypass procedure to be done without harvesting vessels from the body.
Dr. Manny Villafaña:
The Living Legend of Medicine
Dr. Manny Villafaña
Founder & CEO
"I’ve done seven IPOs in the cardiac health space, and Medical 21 is, by far, the company I’m most excited about because of its enormous potential to improve conditions for the millions of coronary artery heart bypass surgery patients."
Learn how you can join Medical 21 in reshaping the future of cardiac bypass surgery.
Medical 21's mission is to make heart bypass surgery safer, less painful, more accessible, and less expensive by eliminating the need for vessel harvesting.
With over 50 years of medtech innovation and 7 IPOs under his belt, Manny Villafaña, Ph.D.Sc. has revolutionized the medical device industry time and time again.
Medical 21 is open to investors through Regulation A+ fundraising, which allows accredited investors and the general public alike to participate.
Learn more about Medical 21 by subscribing and staying up to date on our clinical trials, medical technology, and investment opportunities.
